Edgewise Therapeutics

EWTX | NASDAQ | 0 Followers
$13.11 -0.46% -$0.06
Follow
Overview Metrics Financials
Loading...

Fair Price

$32.32
Undervalued by 26.2%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Edgewise Therapeutics, Inc. is a biotechnology company based in the United States that focuses on the development of therapeutic drugs for rare genetic diseases. The company specializes in innovative approaches in gene therapy and targets conditions such as Duchenne muscular dystrophy and other muscle disorders. Edgewise Therapeutics uses advanced scientific methods to develop drugs with the potential to significantly improve the quality of life for patients suffering from these serious and currently challenging-to-treat conditions.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade